The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

  • This share is currently suspended. It was suspended at a price of 38.80

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: -38.80 (-100.00%)
Open: 38.80
High: 38.80
Low: 38.80
Prev. Close: 38.80
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealings

22 Aug 2023 07:00

RNS Number : 9930J
Accrol Group Holdings PLC
22 August 2023
 

22 August 2023

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

Accrol Group Holdings plc

("Accrol", the "Group" or the "Company")

 

Director Dealings

 

Accrol (AIM:ACRL), the UK's leading independent tissue convertor, has been notified that Dan Wright, the Executive Chairman, and Gareth Jenkins, the Chief Executive Officer have purchased an aggregate of 185,758 ordinary shares of £0.001 each ("Ordinary Shares") at a price of 32.3 pence per Ordinary Share. Details of the dealings are included in the table below:

 

Director

Ordinary Shares purchased

Ordinary Shares beneficially owned

% of issued share capital

Dan Wright

92,879

12,608,422*

3.95%

Gareth Jenkins

92,879

4,515,808**

1.42%

 

* 10,786,972 of these shares are registered in the name of Gomrath Limited, a family investment company controlled by Dan Wright

** 3,741,346 of these shares are registered in the name of Gareth's wife Susan Jenkins

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dan Wright

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001 each

 

 

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

32.3 pence

92,879

d)

Aggregated information

- Aggregated volume

- Price

N/A - Single transaction

e)

Date of the transaction

21 August 2023

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gareth Jenkins

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001 each

 

 

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

32.3 pence

92,879

d)

Aggregated information

- Aggregated volume

- Price

N/A - Single transaction

e)

Date of the transaction

21 August 2023

f)

Place of the transaction

London Stock Exchange, AIM

 

 

For further information, please contact:

 

 

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

Zeus (Nominated Adviser & Joint Broker) 

 

Dan Bate / Jordan Warburton / Kieran Russell

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000

Shore Capital Stockbrokers (Joint Broker)

Tel: +44 (0) 20 7408 4090

Malachy McEntyre / Mark Percy / James Thomas

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

accrolpr@belvederepr.com

 

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which together supply c.21.5% (volume) of the UK tissue market valued at c£2.5bn at retail sales value.

 

For more information, please visit www.accrol.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBFLLLXVLZBBL
Date   Source Headline
18th May 20219:06 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSTrading Update
9th Apr 20217:00 amRNSAcquisition of highly scalable wet wipes business
8th Apr 20216:04 pmRNSCorrection: TR-1
8th Apr 20215:58 pmRNSCorrection: TR-1
30th Mar 20217:00 amRNSTR-1
18th Mar 20213:23 pmRNSTR-1
5th Mar 20217:11 amRNSImplementation of LTIP and PDMR dealing
14th Jan 20217:00 amRNSPDMR Dealings
12th Jan 20217:00 amRNSHalf Year Results
7th Jan 20217:00 amRNSOnline HY 21 Investor Presentation
17th Dec 20207:00 amRNSNotice of Half Year Results
15th Dec 20207:00 amRNSOnline Investor Presentation
14th Dec 202011:05 amRNSSecond Price Monitoring Extn
14th Dec 202011:00 amRNSPrice Monitoring Extension
14th Dec 20209:05 amRNSSecond Price Monitoring Extn
14th Dec 20209:00 amRNSPrice Monitoring Extension
11th Dec 20208:51 amRNSTR-1
2nd Dec 20207:00 amRNSAppointment of Chief Financial Officer
27th Nov 202012:48 pmRNSTR-1
26th Nov 20207:00 amRNSTR-1
25th Nov 20207:00 amRNSCompletion of Acquisition
24th Nov 20201:54 pmRNSTR-1
24th Nov 20201:44 pmRNSTR-1
24th Nov 202011:28 amRNSTR-1
24th Nov 202010:54 amRNSTR-1
24th Nov 20207:00 amRNSPDMR Dealing
23rd Nov 20208:00 amRNSAdmission of Shares & Total Voting Rights
20th Nov 202011:32 amRNSResult of General Meeting
20th Nov 20207:00 amRNSResult of Open Offer
6th Nov 202011:55 amRNSTR-1
4th Nov 20205:13 pmRNSPosting of Circular
3rd Nov 20207:00 amRNSConfirmation of Successful Placing
2nd Nov 20204:59 pmRNSAcquisition and Launch of ABB
2nd Nov 20207:00 amRNSCOVID-19 Business Update
27th Oct 20202:44 pmRNSResult of AGM
25th Sep 20208:00 amRNSNotice of AGM and Posting of Accounts
2nd Sep 20207:00 amRNSAudited Final Results
25th Aug 20207:00 amRNSNotice of Results and Online Investor Presentation
22nd May 202012:40 pmRNSTR-1
21st May 20202:25 pmRNSTR-1
6th May 20207:00 amRNSTrading Update
25th Mar 202010:19 amRNSTR-1
23rd Mar 202011:35 amRNSTR-1
17th Mar 20207:00 amRNSAppointment of Joint Broker
4th Mar 20207:00 amRNSTR-1
3rd Mar 20209:41 amRNSTR-1
29th Jan 20207:00 amRNSDirector's Dealing
21st Jan 20209:13 amRNSTR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.